Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX? adjuvant in women with cervical intraepithelial neoplasia

The causal relation between human papillomavirus and cervical cancer

2002 • 3,451 citations

New generation vaccines

1992 • 675 citations

Options for the control of influenza III

1997 • 591 citations

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer

1996 • 538 citations

A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive.

2000 • 314 citations

Vaccines and Vaccination

2001 • 295 citations

Human papillomavirus 16 load in normal and abnormal cervical scrapes: An indicator of CIN II/III and viral clearance

2002 • 262 citations

Antibodies Against the Human Papillomavirus Type 16 Early Proteins in Human Sera: Correlation of Anti-E7 Reactivity With Cervical Cancer

1989 • 243 citations

Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I–II trial

1999 • 231 citations

Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer.

2002 • 196 citations

ISCOMs and other saponin based adjuvants

1998 • 180 citations

Immunotherapy of human cervical high-grade cervical intraepithelial neoplasia with microparticle-delivered human papillomavirus 16 E7 plasmid DNA

2003 • 147 citations

A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM? vaccines and conventional vaccines

2000 • 142 citations

Augmentation of Human Influenza A Virus-Specific Cytotoxic T Lymphocyte Memory by Influenza Vaccine and Adjuvanted Carriers (ISCOMS)

1999 • 113 citations

Immunology of papillomavirus infection

1996 • 107 citations

Activity of HspE7, a Novel Immunotherapy, in Patients with Anogenital Warts

2002 • 99 citations

Papillomavirus-Like Particle Vaccines

2000 • 73 citations

Design and Validation of an Enzyme-Linked Immunospot Assay for Use in Clinical Trials of Candidate HIV Vaccines

2002 • 72 citations

ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus

1999 • 67 citations

Local immune responses to influenza antigen are synergistically enhanced by the adjuvant ISCOMATRIX®

2001 • 47 citations

Induction of lymphocyte recruitment in the absence of a detectable immune response

2000 • 43 citations

Therapeutic Vaccines for Human Papillomaviruses

2001 • 38 citations

Human Papillomavirus DNA Remains Detectable Longer than Related Cervical Cytologic Abnormalities

2002 • 34 citations

Vaccines for Human Papillomavirus Infection and Anogenital Disease

1999 • 33 citations

Immunotherapy of human papillomavirus-associated malignancies and the challenges posed by T-CELL tolerance

2002 • 8 citations

Deleted Work

1955 • 0 citations